Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	26.14	9.7	0.46	16.58	-
Cash & Short-Term Investments	26.14	9.7	0.46	16.58	-
Cash Growth	169.48%	2032.09%	-97.26%	-	-
Prepaid Expenses	4.81	3.37	2.03	1.71	-
Other Current Assets	-	0.33	0.16	0.13	0.2
Total Current Assets	30.95	13.4	2.64	18.41	0.2
Property, Plant & Equipment	0.72	0.79	0.17	0.33	-
Total Assets	31.67	14.19	2.82	18.74	0.2
Accounts Payable	1.06	0.84	0.89	0.74	0.18
Accrued Expenses	3.56	3.23	2.24	1.21	0.18
Short-Term Debt	-	-	-	-	2.51
Current Portion of Leases	0.56	0.33	0.16	0.15	-
Other Current Liabilities	18.94	13.13	-	-	-
Total Current Liabilities	24.12	17.53	3.28	2.11	2.88
Long-Term Leases	0.12	0.47	-	0.16	-
Total Liabilities	24.24	18	3.28	2.26	2.88
Common Stock	0.11	0.04	0.02	0.02	0.01
Additional Paid-In Capital	108.59	60.7	33.52	32.41	3.24
Retained Earnings	-101.27	-64.54	-34	-15.94	-5.92
Shareholders' Equity	7.43	-3.81	-0.47	16.48	-2.67
Total Liabilities & Equity	31.67	14.19	2.82	18.74	0.2
Total Debt	0.68	0.79	0.16	0.31	2.51
Net Cash (Debt)	25.46	8.91	0.3	16.27	-2.51
Net Cash Growth	185.82%	2869.33%	-98.16%	-	-
Net Cash Per Share	0.38	0.36	0.02	1.39	-0.30
Filing Date Shares Outstanding	119.71	34.76	15.23	15	8.9
Total Common Shares Outstanding	113.84	34.76	15.23	15	8.51
Working Capital	6.83	-4.14	-0.64	16.31	-2.67
Book Value Per Share	0.07	-0.11	-0.03	1.10	-0.31
Tangible Book Value	7.43	-3.81	-0.47	16.48	-2.67
Tangible Book Value Per Share	0.07	-0.11	-0.03	1.10	-0.31
Machinery	-	0.02	0.01	0.01	-
Leasehold Improvements	-	0.02	0.02	0.02	-

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q